Characterization of medroxyprogesterone and DMBA-induced multilineage mammary tumors by gene expression profiling

被引:31
作者
Yin, Y
Bai, R
Russell, RG
Beildeck, ME
Xie, Z
Kopelovich, L
Glazer, RI [1 ]
机构
[1] Georgetown Univ, Dept Oncol, Washington, DC 20057 USA
[2] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
[3] Chemoprevent Agent Dev Res Grp, Div Canc Prevent, NCI, Bethesda, MD USA
关键词
carcinogenesis; DMBA; medroxyprogesterone; mammary; adenocarcinoma; adenosquamous; myoepithelial; squamous; gene microarray;
D O I
10.1002/mc.20119
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mouse mammary tumors arising during medroxyprogesterone-DMBA-mediated mammary carcinogenesis comprised three distinct phenotypes: adenocarcinoma, squamous cell carcinoma, and myoepithelial carcinoma. The molecular signature for each of the three tumor subsets was characterized by gene microarray analysis, and three distinct sets of gene expression profiles were obtained that were corroborated in part by quantitative RT-PCR and immunohistochemistry. These results suggest that this carcinogenesis and gene expression model will be useful for rapidly assessing the histopathological differences arising in mammary carcinogenesis and the effects of tumor promoting or chemoprevention agents. Published 2005 Wiley-Liss, Inc.(dagger)
引用
收藏
页码:42 / 50
页数:9
相关论文
共 51 条
[1]   Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene [J].
Aldaz, CM ;
Liao, QY ;
LaBate, M ;
Johnston, DA .
CARCINOGENESIS, 1996, 17 (09) :2069-2072
[2]  
BATTYANI Z, 1993, PIGM CELL RES, V6, P400
[3]  
Birnbaum D, 2004, INT J ONCOL, V25, P249
[4]   Keratinocyte-specific onset expression in experimental of serine protease BSSP carcinogenesis [J].
Breitenbach, U ;
Tuckermann, JP ;
Gebhardt, C ;
Richter, KH ;
Fürstenberger, G ;
Christofori, G ;
Angel, P .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (03) :634-640
[5]   IGF-2 is a mediator of prolactin-induced morphogenesis in the breast [J].
Brisken, C ;
Ayyannan, A ;
Nguyen, C ;
Heineman, A .
DEVELOPMENTAL CELL, 2002, 3 (06) :877-887
[6]   The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting [J].
Cardiff, RD ;
Anver, MR ;
Gusterson, BA ;
Hennighausen, L ;
Jensen, RA ;
Merino, MJ ;
Rehm, S ;
Russo, J ;
Tavassoli, FA ;
Wakefield, LM ;
Ward, JM ;
Green, JE .
ONCOGENE, 2000, 19 (08) :968-988
[7]   Initiating oncogenic event determines gene-expression patterns of human breast cancer models [J].
Desai, KV ;
Xiao, N ;
Wang, W ;
Gangi, L ;
Greene, J ;
Powell, JI ;
Dickson, R ;
Furth, P ;
Hunter, K ;
Kucherlapati, R ;
Simon, R ;
Liu, ET ;
Green, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) :6967-6972
[8]   Breast cancer stem cells revealed [J].
Dick, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3547-3549
[9]   Elucidation of molecular targets of mammary cancer chemoprevention in the rat by organoselenium compounds using cDNA microarray [J].
El-Bayoumy, K ;
Narayanan, BA ;
Desai, DH ;
Narayanan, NK ;
Pittman, B ;
Amin, SG ;
Schwartz, J ;
Nixon, DW .
CARCINOGENESIS, 2003, 24 (09) :1505-1514
[10]   Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients [J].
Eppenberger, U ;
Kueng, W ;
Schlaeppi, JM ;
Roesel, JL ;
Benz, C ;
Mueller, H ;
Matter, A ;
Zuber, M ;
Luescher, K ;
Litschgi, M ;
Schmitt, M ;
Foekens, JA ;
Eppenberger-Castori, S .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (09) :3129-3136